Next generation Sequencing Market Size, Share, Trends, Growth Outlook

Next generation Sequencing Market is estimated to increase at a Compounded Annual Growth Rate of 19.5% CAGR over the forecast period from 2024 to 2030

The Next generation Sequencing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (NGS Consumables, Sequencing Services, Presequencing Products & Services, NGS Platforms, Bioinformatics, Management & Cloud Computing Solutions, Services for NGS Platforms), By Technology (Sequencing By Synthesis (ION Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Others), By Application (Diagnostics, Drug Discovery & Development, Agricultural & Animal Research, Others), By End-User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Reference Laboratories, Others).

An Introduction to Next generation Sequencing Market in 2024

Next Generation Sequencing (NGS) has revolutionized genomic research and clinical diagnostics by enabling rapid, high-throughput DNA and RNA sequencing with unprecedented accuracy and cost-effectiveness. Leveraging massively parallel sequencing technologies, NGS platforms can analyze entire genomes, transcriptomes, or targeted gene panels, facilitating the detection of genetic mutations, structural variations, and gene expression profiles associated with disease pathology. In both research and clinical settings, NGS is driving discoveries in cancer genomics, rare genetic diseases, pharmacogenomics, and infectious disease epidemiology. With continuous improvements in sequencing chemistry, bioinformatics pipelines, and sample preparation methods, NGS is poised to further accelerate the understanding of human genetics and transform personalized medicine.

Market Trend: Advancements in Clinical Applications of Next-Generation Sequencing (NGS)

A significant trend in the next-generation sequencing (NGS) market is the continuous advancements in clinical applications of NGS technologies. NGS has evolved beyond research applications to become an indispensable tool in clinical diagnostics, offering unprecedented insights into the genetic basis of diseases and facilitating personalized medicine approaches. Recent developments in NGS platforms, sequencing chemistry, and bioinformatics analysis have expanded the scope of clinical NGS testing to include oncology, rare diseases, inherited disorders, infectious diseases, and pharmacogenomics. This trend reflects a growing adoption of NGS-based tests by healthcare providers and laboratories seeking to improve patient care through more accurate diagnosis, prognostication, and treatment selection based on genomic information.

Market Driver: Increasing Demand for Precision Medicine and Genomic Testing

A key driver for the next-generation sequencing (NGS) market is the increasing demand for precision medicine and genomic testing across healthcare sectors. Precision medicine aims to tailor medical treatment and interventions to individual genetic makeup, lifestyle, and environmental factors, offering the potential for more effective and personalized healthcare delivery. NGS technologies play a crucial role in precision medicine initiatives by enabling comprehensive genomic profiling, identification of disease-causing mutations, and prediction of treatment response. The rising prevalence of chronic diseases, cancer, and genetic disorders, coupled with advancements in genomic research and healthcare infrastructure, drives the demand for NGS-based tests and services. This driver fuels market growth and innovation in NGS platforms, assay kits, and bioinformatics solutions designed to meet the evolving needs of clinical laboratories, healthcare providers, and patients.

Market Opportunity: Expansion into Population Genomics and Public Health Genomics

An emerging opportunity within the next-generation sequencing (NGS) market lies in the expansion into population genomics and public health genomics initiatives. Population genomics aims to study genetic variations and disease prevalence within specific populations or geographic regions, providing insights into genetic diversity, ancestry, and disease susceptibility patterns. NGS technologies offer the scalability, throughput, and cost-effectiveness required for large-scale population genomic studies, enabling researchers to identify genetic risk factors, population-specific mutations, and environmental influences on health outcomes. By leveraging NGS for population genomics research, stakeholders can contribute to disease prevention, epidemiological surveillance, and public health interventions tailored to address population-specific health disparities and improve healthcare equity. Collaboration between NGS technology providers, academic institutions, and government agencies can drive innovation and investment in population genomics initiatives, creating opportunities to harness genomic data for public health policy development, disease prevention strategies, and healthcare resource allocation.

Next generation Sequencing Market Share Analysis: Sequencing By Synthesis (SBS) is the fastest growing segment over the forecast period to 2030

Among the diverse segments of the Next Generation Sequencing (NGS) Market, Sequencing By Synthesis (SBS) emerges as the fastest-growing segment, owing to several key factors. SBS technology, characterized by its high throughput and accuracy, enables the parallel sequencing of millions of DNA fragments, making it well-suited for various applications in diagnostics, drug discovery, agriculture, and research. The continuous advancements in SBS platforms, coupled with reductions in sequencing costs and turnaround times, have significantly enhanced its accessibility and utility across different end-user segments, including academic institutes, pharmaceutical companies, hospitals, and reference laboratories. Moreover, the integration of SBS with advanced bioinformatics and cloud computing solutions further expands its analytical capabilities, enabling comprehensive genomic analysis and interpretation. With its versatility, scalability, and continued technological innovations, the Sequencing By Synthesis segment is poised to drive substantial growth in the Next Generation Sequencing Market.

Next generation Sequencing Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across10x Genomics Inc, Agilent Technologies Inc, BGI Group, Brooks Automation Inc, CD Genomics, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc, New England Biolabs Inc, Novogene Corp Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Promega Corp, Psomagen Inc, QIAGEN N.V., Takara Bio Inc, Tecan Group Ltd, Thermo Fisher Scientific Inc, Zymo Research Corp

Next generation Sequencing Market Segmentation

By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Next generation Sequencing Market Companies

10x Genomics Inc
Agilent Technologies Inc
BGI Group
Brooks Automation Inc
CD Genomics
Eurofins Scientific SE
F. Hoffmann-La Roche AG
Illumina Inc
New England Biolabs Inc
Novogene Corp Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Tecan Group Ltd
Thermo Fisher Scientific Inc
Zymo Research Corp

Reasons to Buy the Next generation Sequencing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Next generation Sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Next generation Sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Next generation Sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Next generation Sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 Next generation Sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Next generation Sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Next generation Sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Next generation Sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Next generation Sequencing Industry
4.2 Key Market Trends in Next generation Sequencing Industry
4.3 Potential Opportunities in Next generation Sequencing Industry
4.4 Key Challenges in Next generation Sequencing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Next generation Sequencing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Next generation Sequencing Market Outlook by Segments
7.1 Next generation Sequencing Market Outlook by Segments, $ Million, 2021- 2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others

8 North America Next generation Sequencing Market Analysis and Outlook To 2030
8.1 Introduction to North America Next generation Sequencing Markets in 2024
8.2 North America Next generation Sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Next generation Sequencing Market size Outlook by Segments, 2021-2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others

9 Europe Next generation Sequencing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Next generation Sequencing Markets in 2024
9.2 Europe Next generation Sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Next generation Sequencing Market Size Outlook by Segments, 2021-2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others

10 Asia Pacific Next generation Sequencing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Next generation Sequencing Markets in 2024
10.2 Asia Pacific Next generation Sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Next generation Sequencing Market size Outlook by Segments, 2021-2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others

11 South America Next generation Sequencing Market Analysis and Outlook To 2030
11.1 Introduction to South America Next generation Sequencing Markets in 2024
11.2 South America Next generation Sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Next generation Sequencing Market size Outlook by Segments, 2021-2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others
12 Middle East and Africa Next generation Sequencing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Next generation Sequencing Markets in 2024
12.2 Middle East and Africa Next generation Sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Next generation Sequencing Market size Outlook by Segments, 2021-2030
By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
10x Genomics Inc
Agilent Technologies Inc
BGI Group
Brooks Automation Inc
CD Genomics
Eurofins Scientific SE
F. Hoffmann-La Roche AG
Illumina Inc
New England Biolabs Inc
Novogene Corp Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Tecan Group Ltd
Thermo Fisher Scientific Inc
Zymo Research Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
NGS Consumables
Sequencing Services
Presequencing Products & Services
NGS Platforms
Bioinformatics
Management & Cloud Computing Solutions
Services for NGS Platforms
By Technology
Sequencing By Synthesis
ION Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
Others
By Application
Diagnostics
Drug Discovery & Development
Agricultural & Animal Research
Others
By End-User
Academic Institutes & Research Centers
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Reference Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)